EUCTR2013-001592-20-NL
Active, not recruiting
Not Applicable
Pilot study for studying the influence of low-dose propofol on the classification of movements from the electroencephalogram in healthyparticipants
Not provided0 sitesJune 6, 2013
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Intraoperative awareness during general anesthesia
- Sponsor
- Not provided
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-18\-65 years old
- •\-right\-handed
- •\-normal or corrected to normal vision
- •\-normal or corrected to normal hearing
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 12
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\-neurological impairment
- •\-motor disabilities
- •\-known allergies or oversensitivity to propofol
- •\-allergies to peanuts and/or soy
- •\-cardiac respiratory, renal or hepatic impairment
- •\-regular drug intake (of any kind, other than contraceptives and antihistamines)
- •\-pregnancy or nursing
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pilot study for studying the influence of low-dose propofol on the classification of movements from the electroencephalogram in healthy participantsperioperatieve monitoringmonitoring during anesthesiaNL-OMON38459niversitair Medisch Centrum Sint Radboud12
Recruiting
Not Applicable
Pilot study on the efficacy and safty of low-dose tocilizumab therapy in elderly RA patientsRheumatoid arthritisJPRN-UMIN000008185Kyushu University Beppu Hospital Department of Metabolism, Hematology and Rheumatic Diseases (DMHRDs)10
Active, not recruiting
Not Applicable
ow doses of Rituximab in Graves orbitopathyActive moderate to severe Graves OrbitopathyMedDRA version: 14.1Level: PTClassification code 10060742Term: Endocrine ophthalmopathySystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2012-001980-53-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO10
Not yet recruiting
Phase 1
ow Dose Whole Lung Radiation Therapy for COVID-19 PneumoniaCTRI/2021/06/034115ot yet applied
Withdrawn
Phase 3
A single arm, open label pilot study of low dose regular opioids with low dose regular benzodiazepines for the relief of refractory breathlessness.ACTRN12610000589088Flinders University10